Transcatheter heart valves technologies

Long‐term outcomes after transcatheter aortic valve replacement: Meta‐analysis of Kaplan−Meier‐derived data

Published on 02/11/2023 | Junichi ShimamuraMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30854 | 18 minute read

Abstract Background Transcatheter aortic valve replacement (TAVR) is as an alternative treatment to surgical AVR, but the long‐term outcomes of

Transcatheter heart valves technologies

Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV)

Published on 19/10/2023 | Juan Sánchez-Ceña a et al. | Expert Review of Cardiovascular Therapy 2023; aop:10.1080/14779072.2023.2266368 | 0 minute read

Transcatheter heart valves technologies

Impact of gender, ethnicity and social deprivation on access to surgical or transcatheter aortic valve replacement in aortic stenosis: a retrospective database study in England

Published on 19/10/2023 | Caoimhe T Rice 1 et al. | Open Heart 2023; 10(2): e002373 | 27 minute read

Abstract Objective To assess gender, ethnicity, and deprivation-based differences in provision of aortic valve replacement (AVR) in England for adults

Transcatheter heart valves technologies

Prognostic Value of Patient‐Reported Outcomes in Predicting Long‐Term Mortality After Transcatheter Aortic Valve Replacement

Published on 05/10/2023 | Hasan S.AlarouriMBBS 1 et al. | Journal of the American Heart Association 2023; 12(19): 030383 | 21 minute read

Abstract Background Patient‐reported outcome measures have been shown to have important prognostic value after various cardiac interventions. We assessed the

Transcatheter heart valves technologies

Impact of stroke history on procedural cerebrovascular insult probability and long‐term outcome after TAVI

Published on 05/10/2023 | CaglayanDemirel 1 et al. | European Journal of Clinical Investigation 2023; AOP: 10.1111/eci.14099 | 14 minute read

Abstract Background In TAVI procedural stroke is one of the most feared complications and for this reason also extensively studied.

Transcatheter heart valves technologies

Physician-Modified Endograft-Facilitated Transcatheter Pulmonary Valve Replacement in Large Right Ventricular Outflow Tract

Published on 21/09/2023 | Ueyama et al. | Circulation: Cardiovascular Interventions 2023; 16(9): e013123 | 18 minute read

Abstract Background Transcatheter pulmonary valve replacement (TPVR) in patients with a congenital or acquired abnormality resulting in enlarged right ventricular

Transcatheter heart valves technologies

Mechanisms and implications of mitral regurgitation in patients with severe aortic stenosis who received transcatheter aortic valve replacement

Published on 21/09/2023 | Hitomi HorinouchiMD et al. | Echocardiography 2023; AOP: 10.1111/echo.15693 | 19 minute read

Abstract Introduction This study aimed to investigate the mechanisms and clinical implications of mitral regurgitation (MR) in patients with severe

Transcatheter heart valves technologies

Comparison of costs associated with transcatheter mitral valve repair: PASCAL vs MitraClip in a real-world setting

Published on 07/09/2023 | Haurand Jean Marc 1 et al. | BMC Health Services Research 2023; 23(1): 945 | 25 minute read

Abstract Aims We aimed to conduct a clinical process cost analysis to evaluate all upcoming costs of mitral valve transcatheter

Transcatheter heart valves technologies

Clinical value of CT‐derived simulations of transcatheter‐aortic‐valve‐implantation in challenging anatomies the PRECISE‐TAVI trial

Published on 07/09/2023 | Thijmen W. HokkenMD 1 et al. | Catheterization and Cardiovascular Interventions 2023; AOP: 10.1002/ccd.30816 | 18 minute read

Abstract Background Preprocedural computed tomography planning improves procedural safety and efficacy of transcatheter aortic valve implantation (TAVI). However, contemporary imaging

Transcatheter heart valves technologies

Transapical transcatheter mitral valve implantation with J-valve in patients with degenerated mitral bioprostheses

Published on 17/08/2023 | He Fan et al. | BMC Cardiovascular Disorders 2023; 23(1): 395 | 10 minute read

Abstract Background Due to the widespread application of bioprosthetic valve in the treatment of mitral valve disease in recent years,

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.